Recombinant multi-species CDK13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CDK13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the cyclin-dependent serine/threonine protein kinase family. Members of this family are well known for their essential roles as master switches in cell cycle control. The exact function of this protein has not yet been determined, but it may play a role in mRNA processing and may be involved in regulation of hematopoiesis. Alternatively spliced transcript variants have been described.[provided by RefSeq, Dec 2009]
The Alternative Names of target: 2310015O17Rik,CDC2-related protein kinase 5,CDC2L,CDC2L5,CDK13,CHDFIDD,CHED,Cdc2l5,Cdk13,Cell division cycle 2-like protein kinase 5,Cell division protein kinase 13 (hCDK13),Cholinesterase-related cell division controller,Cyclin-dependent kinase 13,hCDK13

Target products collectionGo to CDK13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T74839-Ag-1/ GM-Tg-hg-T74839-Ag-2 Human CDK13 protein Human
GM-Tg-rg-T74839-Ag-1/ GM-Tg-rg-T74839-Ag-2 Rat CDK13 protein Rat
GM-Tg-mg-T74839-Ag-1/ GM-Tg-mg-T74839-Ag-2 Mouse CDK13 protein Mouse
GM-Tg-cynog-T74839-Ag-1/ GM-Tg-cynog-T74839-Ag-2 Cynomolgus/Rhesus macaque CDK13 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T74839-Ag-1/ GM-Tg-felg-T74839-Ag-2 Feline CDK13 protein Feline
GM-Tg-cang-T74839-Ag-1/ GM-Tg-cang-T74839-Ag-2 Canine CDK13 protein Canine
GM-Tg-bovg-T74839-Ag-1/ GM-Tg-bovg-T74839-Ag-2 Bovine CDK13 protein Bovine
GM-Tg-equg-T74839-Ag-1/ GM-Tg-equg-T74839-Ag-2 Equine CDK13 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T74839-Ag-1/ GM-Tg-hg-T74839-Ag-2; GM-Tg-rg-T74839-Ag-1/ GM-Tg-rg-T74839-Ag-2;
GM-Tg-mg-T74839-Ag-1/ GM-Tg-mg-T74839-Ag-2; GM-Tg-cynog-T74839-Ag-1/ GM-Tg-cynog-T74839-Ag-2;
GM-Tg-felg-T74839-Ag-1/ GM-Tg-felg-T74839-Ag-2; GM-Tg-cang-T74839-Ag-1/ GM-Tg-cang-T74839-Ag-2;
GM-Tg-bovg-T74839-Ag-1/ GM-Tg-bovg-T74839-Ag-2; GM-Tg-equg-T74839-Ag-1/ GM-Tg-equg-T74839-Ag-2
Products Name CDK13 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CDK13
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CDK13 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.